Tenaya Therapeutics (TNYA) Current Assets (2020 - 2026)

Tenaya Therapeutics has reported Current Assets for 7 years, with the latest figure at $96.6 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 2.2% year-over-year to $96.6 million; the trailing twelve-month figure through Mar 2026 stood at $96.6 million (up 2.2% YoY), and the FY2025 full-year result was $105.6 million, up 56.71% from the prior year.
• Current Assets for Q1 2026 stood at $96.6 million, down from $105.6 million in the prior quarter.
• The five-year high for Current Assets was $213.8 million in Q1 2022, with the low at $61.2 million in Q3 2025.
• Average Current Assets over 5 years is $123.7 million, with a median of $111.6 million recorded in 2023.
• Peak annual rise in Current Assets reached 64.01% in 2022, while the deepest fall reached 44.85% in 2022.
• Tracing TNYA's Current Assets over 5 years: stood at $193.8 million in 2022, then sank by 42.41% to $111.6 million in 2023, then tumbled by 39.62% to $67.4 million in 2024, then surged by 56.71% to $105.6 million in 2025, then declined by 8.55% to $96.6 million in 2026.
• The last three Current Assets figures came in at $96.6 million (Q1 2026), $105.6 million (Q4 2025), and $61.2 million (Q3 2025), per Business Quant data.

Peer Comparison